Technical Analysis for CVM - Cel-Sci Corporation

Grade Last Price % Change Price Change
F 15.74 -2.54% -0.41
CVM closed down 2.54 percent on Tuesday, April 13, 2021, on 1.25 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical CVM trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
20 DMA Resistance Bearish -2.54%
Shooting Star Candlestick Bearish -2.54%
Lizard Bearish Bearish Day Trade Setup -2.54%
Pocket Pivot Bullish Swing Setup -2.54%
Volume Surge Other -2.54%
Wide Range Bar Range Expansion -2.54%
Doji - Bearish? Reversal -2.54%
Doji - Bullish? Reversal -2.54%
Outside Day Range Expansion -2.54%
Older End-of-Day Signals for CVM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 7 hours ago
Rose Above 10 DMA about 9 hours ago
60 Minute Opening Range Breakdown about 10 hours ago
Down 3% about 10 hours ago
Lizard Bearish Entry about 10 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cel-Sci Corporation Description

CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer. The Multikine is an immunotherapeutic agent consisting of a mixture of cytokines that produce an anti-tumor immune response. It also develops Ligand Epitope Antigen Presentation System (LEAPs), a heteroconjugate technology that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, develops a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is based in Vienna, Virginia.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Immunology Immune System Immunotherapy Rheumatoid Arthritis Vaccine Vaccination Autoimmunity Transplantation Head And Neck Cancer Immune Response Cytokine Cytokines Allergies Antigen Treatment Of Head And Neck Cancer

Is CVM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 40.91
52 Week Low 10.37
Average Volume 855,971
200-Day Moving Average 14.86
50-Day Moving Average 19.05
20-Day Moving Average 16.93
10-Day Moving Average 16.26
Average True Range 1.63
ADX 14.69
+DI 26.41
-DI 22.54
Chandelier Exit (Long, 3 ATRs ) 16.86
Chandelier Exit (Short, 3 ATRs ) 18.75
Upper Bollinger Band 19.42
Lower Bollinger Band 14.44
Percent B (%b) 0.26
BandWidth 29.43
MACD Line -0.69
MACD Signal Line -0.67
MACD Histogram -0.0156
Fundamentals Value
Market Cap 607.94 Million
Num Shares 38.6 Million
EPS -1.12
Price-to-Earnings (P/E) Ratio -14.00
Price-to-Sales 0.00
Price-to-Book 24.94
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.81
Resistance 3 (R3) 17.81 17.12 17.47
Resistance 2 (R2) 17.12 16.59 17.12 17.35
Resistance 1 (R1) 16.43 16.27 16.09 16.43 17.23
Pivot Point 15.74 15.74 15.57 15.74 15.74
Support 1 (S1) 15.05 15.21 14.71 15.05 14.25
Support 2 (S2) 14.36 14.89 14.36 14.13
Support 3 (S3) 13.67 14.36 14.02
Support 4 (S4) 13.67